Multiple sclerosis

At the ENU innovative treatments for multiple sclerosis are tested in the EAE model, in parallel to pathogenetic studies in vivo, ex vivo and in vitro.Experimental studies on possible disease biomarkers are performed in collaboration with the Neuroimmunology Center at